secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001824293-24-000023
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio implements 1-for-7 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------

- Effective 4:01 p.m. ET Jan 29, 2024; post-split trading begins Jan 30 under symbol GRI.
- Outstanding shares reduced from ~4,520,233 to ~645,736; authorized shares unchanged.
- Proportional adjustments to per-share exercise price and shares issuable under outstanding options, warrants, and convertible securities.
- No fractional shares issued; stockholders receive cash in lieu based on Jan 29 closing price.
- Stockholder-approved at Jan 19 special meeting; intended to regain Nasdaq minimum bid price compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000023/0001824293-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000023/val-20240129.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer